Stock & Company Details
Alx Oncology Holdings Inc $ALXO
Price:
N/A
N/A
138M
$163M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.79
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Commercial Services
ALXO technical indicators
Latest Alx Oncology Holdings Inc (ALXO) indicator readings as of 2026-10-09.
ALXO's 14-day RSI is 34.1, in neutral territory. At $1.25 it is trading 31.9% below its 200-day moving average of $1.83, and below its 50-day average of $1.77. Price sits in the middle of its Bollinger Bands ($0.95 to $1.95). ADX reads 40.7, indicating a trending market.
Overview
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Finance Bot
Ask your questions
Start by typing a question below.
